AZD3480, a novel nicotinic receptor agonist, for the treatment of attention-deficit/hyperactivity disorder in adults

Biological Psychiatry

Volumn 75, Issue 3, 2014, Pages 207-214

  Potter, Alexandra S ^a   Dunbar, Geoffrey ^b   Mazzulla, Emily ^a   Hosford, David ^b   Newhouse, Paul A ^c  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b TARGACEPT INC   (United States)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

Acetylcholine; ADHD; AZD3480; cognition; nicotinic; therapeutic

Indexed keywords

ACETYLCHOLINE; ISPRONICLINE; NICOTINIC AGENT; PLACEBO;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HYPERACTIVITY; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VISUAL DISORDER; YOUNG ADULT;

ACETYLCHOLINE; ADHD; AZD3480; COGNITION; NICOTINIC; THERAPEUTIC;

ADOLESCENT; ADULT; AGED; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; COGNITION DISORDERS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; NICOTINIC AGONISTS; PSYCHIATRIC STATUS RATING SCALES; PYRIDINES; YOUNG ADULT;

EID: 84891590135     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2013.06.002     Document Type: Article

References (71)

1. RA Barkley, M Fischer, L Smallish, and K Fletcher The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder J Abnorm Psychol 111 2002 279 289 (Pubitemid 34441206)
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, 4th ed., text revision. 2000 American Psychiatric Association Washington, DC
3. J. Biederman, S.V. Faraone, T. Spencer, T. Wilens, D. Norman, and K.A. Lapey et al. Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder Am J Psychiatry 150 1993 1792 1798 (Pubitemid 23356570)
4. S.V. Faraone, J. Biederman, T. Spencer, T. Wilens, L.J. Seidman, and E. Mick et al. Attention-deficit/hyperactivity disorder in adults: an overview Biol Psychiatry 48 2000 9 20 (Pubitemid 30407145)
5. A.S. Hervey, J.N. Epstein, and J.F. Curry Neuropsychology of adults with attention-deficit/hyperactivity disorder: a meta-analytic review Neuropsychology 18 2004 485 503 (Pubitemid 38944385)
6. J.A. Lieberman, J.A. Javitch, and H. Moore Cholinergic agonists as novel treatments for schizophrenia: the promise of rational drug development for psychiatry Am J Psychiatry 165 2008 931 936
7. A.E. Doyle, S.V. Faraone, L.J. Seidman, E.G. Willcutt, J.T. Nigg, and I.D. Waldman et al. Are endophenotypes based on measures of executive functions useful for molecular genetic studies of ADHD? J Child Psychol Psychiatry 46 2005 774 803 (Pubitemid 40932960)
8. S. Durston, P. de Zeeuw, and W.G. Staal Imaging genetics in ADHD: A focus on cognitive control Neurosci Biobehav Rev 33 2009 674 689
9. J.T. Nigg, L.G. Blaskey, J.A. Stawicki, and J. Sachek Evaluating the endophenotype model of ADHD neuropsychological deficit: Results for parents and siblings of children with ADHD combined and inattentive subtypes J Abnorm Psychol 113 2004 614 625 (Pubitemid 39431115)
10. D.I. Slaats-Willemse, H. Swaab-Barneveld, L. de Sonneville, E. van der Meulen, and J. Buitelaar Deficient response inhibition as a cognitive endophenotype of ADHD J Am Acad Child Adolesc Psychiatry 42 2003 1242 1248 (Pubitemid 39592078)
11. E.G. Willcutt, A.E. Doyle, J.T. Nigg, S.V. Faraone, and B.F. Pennington Validity of the executive function theory of attention-deficit/hyperactivity disorder: A meta-analytic review Biol Psychiatry 57 2005 1336 1346 (Pubitemid 40798553)
12. L.J. Seidman, J. Biederman, S.V. Faraone, S. Milberger, D. Norman, and K. Seiverd et al. Effects of family history and comorbidity on the neuropsychological performance of children with ADHD: Preliminary findings J Am Acad Child Adolesc Psychiatry 34 1995 1015 1024
13. J. Crosbie, and R. Schachar Deficient inhibition as a marker for familial ADHD Am J Psychiatry 158 2001 1884 1890 (Pubitemid 33054783)
14. A.R. Aron, and R.A. Poldrack The cognitive neuroscience of response inhibition: Relevance for genetic research in attention-deficit/hyperactivity disorder Biol Psychiatry 57 2005 1285 1292 (Pubitemid 40798547)
15. J.T. Jorgensen Are we approaching the post-blockbuster era? Pharmacodiagnostics and rational drug development Exp Rev Mol Diagn 8 2008 689 695
16. L.L. Greenhill, J.M. Perel, G. Rudolph, B. Feldman, S. Curran, and J. Puig-Antich et al. Correlations between motor persistence and plasma levels in methylphenidate-treated boys with ADHD Int J Neuropsychopharmacol 4 2001 207 215 (Pubitemid 32587389)
17. J.M. Swanson, S. Wigal, L.L. Greenhill, R. Browne, B. Waslik, and M. Lerner et al. Analog classroom assessment of Adderall in children with ADHD J Am Acad Child Adolesc Psychiatry 37 1998 519 526 (Pubitemid 28196927)
18. M. Fischer, R.A. Barkley, C.S. Edelbrock, and L. Smallish The adolescent outcome of hyperactive children diagnosed by research criteria: II. Academic, attentional, and neuropsychological status J Consult Clin Psychol 58 1990 580 588 (Pubitemid 20356000)
19. S. Durston A review of the biological bases of ADHD: What have we learned from imaging studies? Ment Retard Dev Disabil Res Rev 9 2003 184 195 (Pubitemid 37128493)
20. A.S. Potter, P.A. Newhouse, and D.J. Bucci Central nicotinic cholinergic systems: A role in the cognitive dysfunction in attention-deficit/hyperactivity disorder? Behav Brain Res 175 2006 201 211 (Pubitemid 44750245)
21. O.F. Pomerleau, K.K. Downey, F.W. Stelson, and C.S. Pomerleau Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder J Subst Abuse 7 1995 373 378 (Pubitemid 26032582)
22. S. Milberger, J. Biederman, S.V. Faraone, L. Chen, and J. Jones ADHD is associated with early initiation of cigarette smoking in children and adolescents J Am Acad Child Adolesc Psychiatry 36 1997 37 44 (Pubitemid 27024226)
23. N.M. Lambert, and C.S. Hartsough Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants [see comment] J Learning Disabil 31 1998 533 544
24. C. Lerman, J. Audrain, K. Tercyak, L.W. Hawk Jr, A. Bush, and S. Crystal-Mansour et al. Attention-deficit hyperactivity disorder (ADHD) symptoms and smoking patterns among participants in a smoking-cessation program Nicotine Tob Res 3 2001 353 359 (Pubitemid 33101062)
25. T.E. Wilens, M. Vitulano, H. Upadhyaya, J. Adamson, R. Sawtelle, and L. Utzinger et al. Cigarette smoking associated with attention deficit hyperactivity disorder J Pediatr 153 2008 414 419
26. S.H. Kollins, F.J. McClernon, and B.F. Fuemmeler Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults Arch Gen Psychiatry 62 2005 1142 1147 (Pubitemid 41396939)
27. E.D. Levin, and A.H. Rezvani Nicotinic treatment for cognitive dysfunction Curr Drug Targets CNS Neurol Disord 1 2002 423 431
28. P.A. Newhouse, A. Potter, and A. Singh Effects of nicotinic stimulation on cognitive performance Curr Opin Pharmacol 4 2004 36 46 (Pubitemid 38145836)
29. K.A. Sacco, K.L. Bannon, and T.P. George Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders J Psychopharmacol 18 2004 457 474 (Pubitemid 39665114)
30. E.D. Levin, F.J. McClernon, and A.H. Rezvani Nicotinic effects on cognitive function: Behavioral characterization, pharmacological specification, and anatomic localization Psychopharmacology 184 2006 523 539 (Pubitemid 43255869)
31. E.D. Levin, C.K. Conners, E. Sparrow, S.C. Hinton, D. Erhardt, and W.H. Meck et al. Nicotine effects on adults with attention-deficit/hyperactivity disorder Psychopharmacology (Berl) 123 1996 55 63
32. A. Singh, A. Potter, and P. Newhouse Nicotinic acetylcholine receptor system and neuropsychiatric disorders IDrugs 7 2004 1096 1103 (Pubitemid 40123635)
33. T.E. Wilens, T.J. Spencer, and J. Biederman A review of the pharmacotherapy of adults with attention-deficit/hyperactivity disorder J Atten Disord 5 2002 189 202 (Pubitemid 44844205)
34. C.K. Conners, E.D. Levin, E. Sparrow, S.C. Hinton, D. Erhardt, and W.H. Meck et al. Nicotine and attention in adult attention deficit hyperactivity disorder (ADHD) Psychopharmacol Bull 32 1996 67 73 (Pubitemid 26176204)
35. J.G. Gehricke, N. Hong, C.K. Whalen, K. Steinhoff, and T.L. Wigal Effects of transdermal nicotine on symptoms, moods, and cardiovascular activity in the everyday lives of smokers and nonsmokers with attention-deficit/hyperactivity disorder Psychol Addict Behav 23 2009 644 655
36. D.V. Poltavski, and T. Petros Effects of transdermal nicotine on attention in adult non-smokers with and without attentional deficits Physiol Behav 87 2006 614 624 (Pubitemid 43356697)
37. A.S. Potter, and P.A. Newhouse Acute nicotine improves cognitive deficits in young adults with attention-deficit/hyperactivity disorder Pharmacol Biochem Behav 88 2008 407 417 (Pubitemid 350266783)
38. A.S. Potter, and P.A. Newhouse Effects of acute nicotine administration on behavioral inhibition in adolescents with attention-deficit/hyperactivity disorder Psychopharmacology (Berl) 176 2004 182 194 (Pubitemid 39517948)
39. R.D. Shytle, A.A. Silver, B.J. Wilkinson, and P.R. Sanberg A pilot controlled trial of transdermal nicotine in the treatment of attention deficit hyperactivity disorder World J Biol Psychiatry 3 2002 150 155
40. T.E. Wilens, and M.W. Decker Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: Focus on cognition Biochem Pharmacol 74 2007 1212 1223 (Pubitemid 47417927)
41. T.E. Wilens, J. Biederman, T.J. Spencer, J. Bostic, J. Prince, and M.C. Monuteaux et al. A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder Am J Psychiatry 156 1999 1931 1937
42. T.E. Wilens, M.H. Verlinden, L.A. Adler, P.J. Wozniak, and S.A. West ABT-089, a neuronal nicotinic receptor partial agonist, for the treatment of attention-deficit/hyperactivity disorder in adults: Results of a pilot study Biol Psychiatry 59 2006 1065 1070 (Pubitemid 43849655)
43. T.E. Wilens, J. Biederman, J. Wong, T.J. Spencer, and J.B. Prince Adjunctive donepezil in attention deficit hyperactivity disorder youth: Case series J Child Adolesc Psychopharmacol 10 2000 217 222
44. J. Biederman, E. Mick, S. Faraone, P. Hammerness, C. Surman, and T. Harpold et al. A double-blind comparison of galantamine hydrogen bromide and placebo in adults with attention-deficit/hyperactivity disorder: A pilot study J Clin Psychopharmacol 26 2006 163 166 (Pubitemid 43740340)
45. T.E. Wilens, J. Waxmonsky, M. Scott, A. Swezey, A. Kwon, and T.J. Spencer et al. An open trial of adjunctive donepezil in attention-deficit/hyperactivity disorder J Child Adolesc Psychopharmacol 15 2005 947 955 (Pubitemid 43042986)
46. R. Joober On the simple and the complex in psychiatry, with reference to DSM 5 and Research Domain Criteria J Psychiatry Neurosci 38 2013 148 151
47. J. Crosbie, P. Arnold, A. Paterson, J. Swanson, A. Dupuis, and X. Li et al. Response inhibition and ADHD traits: Correlates and heritability in a community sample J Abnorm Child Psychol 31 2013 497 507
48. S.B. Campbell, and C. von Stauffenberg Delay and inhibition as early predictors of ADHD symptoms in third grade J Abnorm Child Psychol 37 2009 1 15
49. S. Verte, H.M. Geurts, H. Roeyers, J. Oosterlaan, and J.A. Sergeant The relationship of working memory, inhibition, and response variability in child psychopathology J Neurosci Methods 151 2006 5 14 (Pubitemid 43233696)
50. T.R. Wodushek, and C.S. Neumann Inhibitory capacity in adults with symptoms of attention deficit/hyperactivity disorder (ADHD) Arch Clin Neuropsychol 18 2003 317 330 (Pubitemid 36369369)
51. A.S. Potter, D.J. Bucci, and P.A. Newhouse Manipulation of nicotinic acetylcholine receptors differentially affects behavioral inhibition in human subjects with and without disordered baseline impulsivity Psychopharmacology (Berl) 220 2012 331 340
52. G. Dunbar, P.H. Boeijinga, A. Demazieres, C. Cisterni, R. Kuchibhatla, and K. Wesnes et al. Effects of TC-1734 (AZD3480), a selective neuronal nicotinic receptor agonist, on cognitive performance and the EEG of young healthy male volunteers Psychopharmacology (Berl) 191 2007 919 929 (Pubitemid 46399143)
53. G.C. Dunbar, F. Inglis, R. Kuchibhatla, T. Sharma, M. Tomlinson, and J. Wamsley Effect of ispronicline, a neuronal nicotinic acetylcholine receptor partial agonist, in subjects with age associated memory impairment (AAMI) J Psychopharmacol 21 2007 171 178 (Pubitemid 46280469)
54. G. Dunbar, A. Demazieres, A. Monreal, C. Cisterni, D. Metzger, and R. Kuchibhatla et al. Pharmacokinetics and safety profile of ispronicline (TC-1734), a new brain nicotinic receptor partial agonist, in young healthy male volunteers J Clin Pharmacol 46 2006 715 726 (Pubitemid 43882795)
55. M.B. First, R.L. Spitzer, M. Gibbon, and J. Williams Structured Clinical Interview for DSM-IV Axis I Disorders - Patient Edition, Version 2.0 1996 New York State Psychiatric Institute New York
56. J. Kaufman, B. Birmaher, D. Brent, U. Rao, C. Flynn, and P. Moreci et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children - Present and Lifetime Version (K-SADS-PL): initial reliability and validity data [see comment] J Am Acad Child Adolesc Psychiatry 36 1997 980 988 (Pubitemid 27272932)
57. W. Guy Clinical Global Impressions. ECDEU Assessment Manual for Psychopharmacology 1976 National Institute of Mental Health, Early Clinical Drug Evaluation, Psychopharmacology Research Branch Rockville, MD 217 222
58. C.K. Conners Clinical use of rating scales in diagnosis and treatment of attention-deficit/hyperactivity disorder Pediatr Clin North Am 46 1999 857 870 vi (Pubitemid 29477877)
59. D. Wechsler Wechsler Abbreviated Scales of Intelligence 1999 The Psychological Corporation San Antonio, TX
60. G.D. Logan On the ability to inhibit thought and action: A users guide to the stop signal paradigm D. Dagenbach, T.H. Carr, Inhibitory Processes in Attention, Memory and Language 1994 Academic Press San Diego, CA
61. G. Apostol, W. Abi-Saab, C.J. Kratochvil, L.A. Adler, W.Z. Robieson, and L.M. Gault et al. Efficacy and safety of the novel alpha(4)beta(2) neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/ hyperactivity disorder: A randomized, double-blind, placebo-controlled crossover study Psychopharmacology (Berl) 219 2012 715 725
62. Y. Benjamini, and D. Yekutieli The control of the false discovery rate in multiple testing under dependency Ann Stat 29 2001 1165 1188 (Pubitemid 33575263)
63. K.A. Perkins Baseline-dependency of nicotine effects: A review Behav Pharmacol 10 1999 597 615 (Pubitemid 30026054)
64. S.V. Faraone, and S.J. Glatt A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes J Clin Psychiatry 71 2010 754 763
65. R. Freedman, A. Olincy, R.W. Buchanan, J.G. Harris, J.M. Gold, and L. Johnson et al. Initial phase 2 trial of a nicotinic agonist in schizophrenia Am J Psychiatry 165 2008 1040 1047
66. V. Knott, E. Mohr, C. Mahoney, C. Engeland, and V. Ilivitsky Effects of acute nicotine administration on cognitive event-related potentials in tacrine-treated and non-treated patients with Alzheimer's disease Neuropsychobiology 45 2002 156 160 (Pubitemid 34458109)
67. A.S. Potter, K.K. Ryan, and P.A. Newhouse Effects of acute ultra-low dose mecamylamine on cognition in adult attention-deficit/hyperactivity disorder (ADHD) Hum Psychopharmacol 24 2009 309 317
68. M. Sarter, M.E. Hasselmo, J.P. Bruno, and B. Givens Unraveling the attentional functions of cortical cholinergic inputs: Interactions between signal-driven and cognitive modulation of signal detection Brain Res Rev 48 2005 98 111 (Pubitemid 40215784)
69. M.V. Solanto, H. Abikoff, E. Sonuga-Barke, R. Schachar, G.D. Logan, and T. Wigal et al. The ecological validity of delay aversion and response inhibition as measures of impulsivity in AD/HD: A supplement to the NIMH multimodal treatment study of AD/HD J Abnorm Child Psychol 29 2001 215 228 (Pubitemid 33745807)
70. M. Sarter, V. Parikh, and W.M. Howe nAChR agonist-induced cognition enhancement: Integration of cognitive and neuronal mechanisms Biochem Pharmacol 78 2009 658 667
71. M. Sarter, V. Parikh, and W.M. Howe Phasic acetylcholine release and the volume transmission hypothesis: Time to move on Nat Rev Neurosci 10 2009 383 390